93 related articles for article (PubMed ID: 15579308)
1. From the Editors' desk.
Olsen B
Matrix Biol; 2004 Nov; 23(7):417-9. PubMed ID: 15579308
[No Abstract] [Full Text] [Related]
2. Signaling from across the way: transactivation of VEGF receptors by HSPGs.
Selleck SB
Mol Cell; 2006 May; 22(4):431-2. PubMed ID: 16713570
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis.
Klüppel M; Wight TN; Chan C; Hinek A; Wrana JL
Development; 2005 Sep; 132(17):3989-4003. PubMed ID: 16079159
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: growth regulation and the prospect of new cancer therapies.
Sanderson RD; Yang Y; Kelly T; MacLeod V; Dai Y; Theus A
J Cell Biochem; 2005 Dec; 96(5):897-905. PubMed ID: 16149080
[TBL] [Abstract][Full Text] [Related]
5. The role of heparan sulphate proteoglycans in angiogenesis.
Stringer SE
Biochem Soc Trans; 2006 Jun; 34(Pt 3):451-3. PubMed ID: 16709184
[TBL] [Abstract][Full Text] [Related]
6. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3.
Santra M; Santra S; Zhang J; Chopp M
J Neurochem; 2008 Apr; 105(2):324-37. PubMed ID: 18021292
[TBL] [Abstract][Full Text] [Related]
7. Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation.
Takimoto A; Nishizaki Y; Hiraki Y; Shukunami C
Dev Biol; 2009 Aug; 332(2):196-211. PubMed ID: 19464280
[TBL] [Abstract][Full Text] [Related]
8. [Progress in angiogenesis regulation of perlecan].
Liu XH
Sheng Li Ke Xue Jin Zhan; 2006 Jan; 37(1):48-50. PubMed ID: 16683546
[No Abstract] [Full Text] [Related]
9. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
[TBL] [Abstract][Full Text] [Related]
10. Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signalling.
van den Akker NM; Caolo V; Wisse LJ; Peters PP; Poelmann RE; Carmeliet P; Molin DG; Gittenberger-de Groot AC
Cardiovasc Res; 2008 May; 78(2):366-75. PubMed ID: 18093989
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of the expression profile during the entochondrostosis of vascular endothelial growth factor in bone morphogenetic protein 2 induced osteogenesis].
Tang X; Fu DH; Yang SH; Chen YC; Li Q; Yu CN; Xu WH; Li J; Ye SN
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):614-7. PubMed ID: 18844060
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
Presta M; Dell'Era P; Mitola S; Moroni E; Ronca R; Rusnati M
Cytokine Growth Factor Rev; 2005 Apr; 16(2):159-78. PubMed ID: 15863032
[TBL] [Abstract][Full Text] [Related]
13. VEGF and VEGF receptors are differentially expressed in chondrocytes.
Bluteau G; Julien M; Magne D; Mallein-Gerin F; Weiss P; Daculsi G; Guicheux J
Bone; 2007 Mar; 40(3):568-76. PubMed ID: 17085091
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
15. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites.
Mitsi M; Hong Z; Costello CE; Nugent MA
Biochemistry; 2006 Aug; 45(34):10319-28. PubMed ID: 16922507
[TBL] [Abstract][Full Text] [Related]
16. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation.
Kadenhe-Chiweshe A; Papa J; McCrudden KW; Frischer J; Bae JO; Huang J; Fisher J; Lefkowitch JH; Feirt N; Rudge J; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Res; 2008 Jan; 6(1):1-9. PubMed ID: 18234958
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulphate proteoglycans: the sweet side of development.
Häcker U; Nybakken K; Perrimon N
Nat Rev Mol Cell Biol; 2005 Jul; 6(7):530-41. PubMed ID: 16072037
[TBL] [Abstract][Full Text] [Related]
18. [Vascular endothelial growth factor--structure and functions].
Barańska P; Jerczyńska H; Pawłowska Z
Postepy Biochem; 2005; 51(1):12-21. PubMed ID: 16209337
[TBL] [Abstract][Full Text] [Related]
19. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR by estradiol through VEGF in uterus.
Hervé MA; Meduri G; Petit FG; Domet TS; Lazennec G; Mourah S; Perrot-Applanat M
J Endocrinol; 2006 Jan; 188(1):91-9. PubMed ID: 16394178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
